Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer
Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting...
Gespeichert in:
Veröffentlicht in: | Journal of minimally invasive gynecology 2011-09, Vol.18 (5), p.629-633 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 633 |
---|---|
container_issue | 5 |
container_start_page | 629 |
container_title | Journal of minimally invasive gynecology |
container_volume | 18 |
creator | Janco, Jo Marie Tran, MD Hacker, Michele R., ScD, MSPH Konstantinopoulos, Panagiotis A., MD Cannistra, Stephen A., MD Awtrey, Christopher S., MD |
description | Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy. |
doi_str_mv | 10.1016/j.jmig.2011.06.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885911512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553465011003244</els_id><sourcerecordid>885911512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</originalsourceid><addsrcrecordid>eNp9kc2LFDEQxYMo7rr6D3iQvnmatpL0J4iwDH4sDMyCepSQTiqSNt1pk_TA_PemmXUPHjxVFbz34P2KkNcUSgq0eTeW42R_lgwoLaEpAeon5JrWNd9VTdM_fdxruCIvYhwBeAvQPCdXjHbAm4Zdkx8Hucjgo_KLVcXdnIJcMNjkZ5SuuPchFfdOKpxwToXxoTguyU7SuXOxPycfUK8KdXGrT3LeluNJBivnYr-d4SV5ZqSL-Oph3pDvnz5-23_ZHY6f7_a3h52qKKRdJ1sztAa0rPtOd6ofjB7MoLlu-qqtoUXDB6Ur4Nz0umuh1gNlLPcxppId8hvy9pK7BP97xZjEZKNC5-SMfo2i6-qe0pqyrGQXpcqlY0AjlpD7hLOgIDaqYhQbVbFRFdCITDWb3jzEr8OE-tHyF2MWvL8IMJc8WQwiKosbEBtQJaG9_X_-h3_sytnZKul-4Rnj6NcwZ3yCisgEiK_bX7e3UpoRsKrifwBxY58i</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885911512</pqid></control><display><type>article</type><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</creator><creatorcontrib>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</creatorcontrib><description>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</description><identifier>ISSN: 1553-4650</identifier><identifier>EISSN: 1553-4669</identifier><identifier>DOI: 10.1016/j.jmig.2011.06.005</identifier><identifier>PMID: 21803662</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Catheters, Indwelling ; Cisplatin - therapeutic use ; Fallopian Tube Neoplasms - drug therapy ; Fallopian Tube Neoplasms - pathology ; Fallopian Tube Neoplasms - surgery ; Female ; Humans ; Infusions, Parenteral ; Intraperitoneal chemotherapy ; Laparoscopy ; Laparoscopy - methods ; Middle Aged ; Neoplasm Staging ; Obstetrics and Gynecology ; Ovarian cancer ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Paclitaxel - therapeutic use ; Peritoneal Neoplasms - drug therapy ; Peritoneal Neoplasms - pathology ; Peritoneal Neoplasms - surgery ; Peritoneum - surgery ; Retrospective Studies ; Surgery ; Treatment Outcome</subject><ispartof>Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.629-633</ispartof><rights>AAGL</rights><rights>2011 AAGL</rights><rights>Copyright © 2011 AAGL. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</citedby><cites>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1553465011003244$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21803662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janco, Jo Marie Tran, MD</creatorcontrib><creatorcontrib>Hacker, Michele R., ScD, MSPH</creatorcontrib><creatorcontrib>Konstantinopoulos, Panagiotis A., MD</creatorcontrib><creatorcontrib>Cannistra, Stephen A., MD</creatorcontrib><creatorcontrib>Awtrey, Christopher S., MD</creatorcontrib><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><title>Journal of minimally invasive gynecology</title><addtitle>J Minim Invasive Gynecol</addtitle><description>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</description><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Catheters, Indwelling</subject><subject>Cisplatin - therapeutic use</subject><subject>Fallopian Tube Neoplasms - drug therapy</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Intraperitoneal chemotherapy</subject><subject>Laparoscopy</subject><subject>Laparoscopy - methods</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Paclitaxel - therapeutic use</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - pathology</subject><subject>Peritoneal Neoplasms - surgery</subject><subject>Peritoneum - surgery</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>1553-4650</issn><issn>1553-4669</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2LFDEQxYMo7rr6D3iQvnmatpL0J4iwDH4sDMyCepSQTiqSNt1pk_TA_PemmXUPHjxVFbz34P2KkNcUSgq0eTeW42R_lgwoLaEpAeon5JrWNd9VTdM_fdxruCIvYhwBeAvQPCdXjHbAm4Zdkx8Hucjgo_KLVcXdnIJcMNjkZ5SuuPchFfdOKpxwToXxoTguyU7SuXOxPycfUK8KdXGrT3LeluNJBivnYr-d4SV5ZqSL-Oph3pDvnz5-23_ZHY6f7_a3h52qKKRdJ1sztAa0rPtOd6ofjB7MoLlu-qqtoUXDB6Ur4Nz0umuh1gNlLPcxppId8hvy9pK7BP97xZjEZKNC5-SMfo2i6-qe0pqyrGQXpcqlY0AjlpD7hLOgIDaqYhQbVbFRFdCITDWb3jzEr8OE-tHyF2MWvL8IMJc8WQwiKosbEBtQJaG9_X_-h3_sytnZKul-4Rnj6NcwZ3yCisgEiK_bX7e3UpoRsKrifwBxY58i</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Janco, Jo Marie Tran, MD</creator><creator>Hacker, Michele R., ScD, MSPH</creator><creator>Konstantinopoulos, Panagiotis A., MD</creator><creator>Cannistra, Stephen A., MD</creator><creator>Awtrey, Christopher S., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><author>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Catheters, Indwelling</topic><topic>Cisplatin - therapeutic use</topic><topic>Fallopian Tube Neoplasms - drug therapy</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Intraperitoneal chemotherapy</topic><topic>Laparoscopy</topic><topic>Laparoscopy - methods</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Paclitaxel - therapeutic use</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - pathology</topic><topic>Peritoneal Neoplasms - surgery</topic><topic>Peritoneum - surgery</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janco, Jo Marie Tran, MD</creatorcontrib><creatorcontrib>Hacker, Michele R., ScD, MSPH</creatorcontrib><creatorcontrib>Konstantinopoulos, Panagiotis A., MD</creatorcontrib><creatorcontrib>Cannistra, Stephen A., MD</creatorcontrib><creatorcontrib>Awtrey, Christopher S., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of minimally invasive gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janco, Jo Marie Tran, MD</au><au>Hacker, Michele R., ScD, MSPH</au><au>Konstantinopoulos, Panagiotis A., MD</au><au>Cannistra, Stephen A., MD</au><au>Awtrey, Christopher S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</atitle><jtitle>Journal of minimally invasive gynecology</jtitle><addtitle>J Minim Invasive Gynecol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>18</volume><issue>5</issue><spage>629</spage><epage>633</epage><pages>629-633</pages><issn>1553-4650</issn><eissn>1553-4669</eissn><abstract>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21803662</pmid><doi>10.1016/j.jmig.2011.06.005</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-4650 |
ispartof | Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.629-633 |
issn | 1553-4650 1553-4669 |
language | eng |
recordid | cdi_proquest_miscellaneous_885911512 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use Catheters, Indwelling Cisplatin - therapeutic use Fallopian Tube Neoplasms - drug therapy Fallopian Tube Neoplasms - pathology Fallopian Tube Neoplasms - surgery Female Humans Infusions, Parenteral Intraperitoneal chemotherapy Laparoscopy Laparoscopy - methods Middle Aged Neoplasm Staging Obstetrics and Gynecology Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Paclitaxel - therapeutic use Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - pathology Peritoneal Neoplasms - surgery Peritoneum - surgery Retrospective Studies Surgery Treatment Outcome |
title | Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A25%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20Intraperitoneal%20Port%20Placement%20for%20Optimally%20Cytoreduced%20Advanced%20Ovarian%20Cancer&rft.jtitle=Journal%20of%20minimally%20invasive%20gynecology&rft.au=Janco,%20Jo%20Marie%20Tran,%20MD&rft.date=2011-09-01&rft.volume=18&rft.issue=5&rft.spage=629&rft.epage=633&rft.pages=629-633&rft.issn=1553-4650&rft.eissn=1553-4669&rft_id=info:doi/10.1016/j.jmig.2011.06.005&rft_dat=%3Cproquest_cross%3E885911512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885911512&rft_id=info:pmid/21803662&rft_els_id=S1553465011003244&rfr_iscdi=true |